van de Veen D, Bakker C, Peetoom K, Pijnenburg Y, Papma J, de Vugt M
J Alzheimers Dis. 2021; 83(4):1891-1916.
PMID: 34487041
PMC: 8609678.
DOI: 10.3233/JAD-210458.
Quartey M, Nyarko J, Pennington P, Heistad R, Klassen P, Baker G
Front Neurosci. 2018; 12:419.
PMID: 29997470
PMC: 6029266.
DOI: 10.3389/fnins.2018.00419.
Jimenez-Jimenez F, Alonso-Navarro H, Garcia-Martin E, Agundez J
Front Cell Neurosci. 2014; 8:369.
PMID: 25426023
PMC: 4227512.
DOI: 10.3389/fncel.2014.00369.
Magdalinou N, Lees A, Zetterberg H
J Neurol Neurosurg Psychiatry. 2014; 85(10):1065-75.
PMID: 24691581
PMC: 4173749.
DOI: 10.1136/jnnp-2013-307539.
Palmer A, DeKosky S
J Neural Transm Gen Sect. 1993; 91(2-3):135-59.
PMID: 8099796
DOI: 10.1007/BF01245229.
Monoamines in the brain cerebrospinal fluid of facial pain patients.
Bouckoms A, SWEET W, Poletti C, Lavori P, Carr D, Matson W
Anesth Prog. 1993; 39(6):201-8.
PMID: 7504420
PMC: 2148620.
Serotonin nerve cells in Alzheimer's disease.
Mann D, YATES P
J Neurol Neurosurg Psychiatry. 1983; 46(1):96.
PMID: 6842210
PMC: 1027274.
DOI: 10.1136/jnnp.46.1.96.
The effects of probenecid on cyclic adenosine 3',5'-monophosphate levels in cerebrospinal fluid and on brain phosphodiesterase activity in the rat.
Horstmann R, Hammers R, Clarenbach P, Cramer H
Arch Psychiatr Nervenkr (1970). 1983; 233(1):71-6.
PMID: 6305307
DOI: 10.1007/BF00540038.
Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
Palmer A, Sims N, Bowen D, Neary D, Palo J, Wikstrom J
J Neurol Neurosurg Psychiatry. 1984; 47(5):481-4.
PMID: 6204017
PMC: 1027823.
DOI: 10.1136/jnnp.47.5.481.
Dopamine (DA) and serotonin metabolic levels in the cerebrospinal fluid (CSF) in Alzheimer's presenile dementia under basic conditions and after stimulation with cerebral cortex phospholipids (BC-PL).
Argentiero V, Tavolato B
J Neurol. 1980; 224(1):53-8.
PMID: 6157799
DOI: 10.1007/BF00313207.
5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.
Johansson B, ROOS B
Eur J Clin Pharmacol. 1971; 3(4):232-5.
PMID: 5151306
DOI: 10.1007/BF00565012.
Rapid diagnosis of infection by gas-liquid chromatography: analysis of sugars in normal and infected cerebrospinal fluid.
Amundson S, BRAUDE A, Davis C
Appl Microbiol. 1974; 28(2):298-302.
PMID: 4854025
PMC: 186704.
DOI: 10.1128/am.28.2.298-302.1974.
Mass fragmentographic analysis of homovanillic acid and its homoiso analogue in cerebrospinal fluid using the alpha-dideutero acid as internal standard.
Fri C, Wiesel F, Sedvall G
Psychopharmacologia. 1974; 35(4):295-304.
PMID: 4831514
DOI: 10.1007/BF00429220.
Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.
Brogden R, Speight T, Avery G
Drugs. 1971; 2(4):262-400.
PMID: 4340597
DOI: 10.2165/00003495-197102040-00002.
The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome.
Burger P, Vogel F
Am J Pathol. 1973; 73(2):457-76.
PMID: 4271339
PMC: 1904076.
Amine metabolites in the cerbrospinal fluid in Huntington's chorea.
Curzon G, Gumpert J, Sharpe D
J Neurol Neurosurg Psychiatry. 1972; 35(4):514-9.
PMID: 4261957
PMC: 494114.
DOI: 10.1136/jnnp.35.4.514.
Dopamine and disease.
Barbeau A
Can Med Assoc J. 1970; 103(8):824-32.
PMID: 4248929
PMC: 1930531.
Neurochemical aspects of Alzheimer's disease: involvement of membrane phospholipids.
Farooqui A, LISS L, Horrocks L
Metab Brain Dis. 1988; 3(1):19-35.
PMID: 3062351
DOI: 10.1007/BF01001351.
Neurochemical specificity of learning: dopamine and motor learning.
MCENTEE W, Mair R, Langlais P
Yale J Biol Med. 1987; 60(2):187-93.
PMID: 2437709
PMC: 2590304.
Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.
Cramer H, Schaudt D, Rissler K, Strubel D, Warter J, Kuntzmann F
J Neurol. 1985; 232(6):346-51.
PMID: 2416886
DOI: 10.1007/BF00313833.
